Blog

Wishbone Gold Plc (LSE:WSBN) has reported strong exploration progress at its Red Setter Gold Project, confirming a mineralised strike extending more than 3km. Recent drilling has uncovered encouraging gold and copper mineralisation, pointing to the potential scale of a significant gold system. The company plans to advance its work program with additional diamond drilling next year, aiming to refine its geological model and build a clearer picture of the project’s mineral potential.

More about Wishbone Gold

Wishbone Gold Plc is a mining exploration company focused on gold and copper assets. Its flagship Red Setter Gold Project lies within Western Australia’s Paterson Range, a region known for major discoveries and located near the established Telfer gold mine.

MJ Gleeson plc (LSE:GLE) reported a 22% rise in net reservation rates for its Gleeson Homes division, even as broader housing demand remains muted due to economic uncertainty. Since the start of FY26, the company has opened six new build sites and launched sales at five additional locations. Gleeson Land completed the disposal of two smaller sites and remains on track with its growth targets, including plans to submit 18 planning applications in the first half of the financial year. The Board expects full-year results to meet market expectations and will provide a trading update in January 2026.

The company’s outlook is supported by a solid balance sheet and a fair valuation profile, though profitability margin pressures and fluctuating cash flow temper overall confidence. Technical indicators offer a mixed picture, showing short-term positive momentum alongside potential emerging downside risk.

More about MJ Gleeson plc

MJ Gleeson plc operates two core divisions: Gleeson Homes, which builds affordable, high-quality homes across the Midlands and North of England, and Gleeson Land, which promotes and sells land for residential development across southern and central regions. The group emphasizes affordability, designing homes accessible to buyers earning the National Living Wage, while its land division focuses on unlocking value through planning and strategic site sales.

MicroSalt (LSE:SALT) delivered an upbeat trading update, posting unaudited sales of $1.66 million for the first ten months of 2025—exceeding initial expectations. The company has deepened its relationship with a major North American customer, forecasting material sales increases in 2026 and 2027, and has signed a non-binding term sheet for a Joint Development Agreement aimed at lowering sodium levels in food products. MicroSalt also entered a strategic partnership with plant-based producer Daiya Foods, further strengthening its growth outlook for the years ahead. Together, these initiatives highlight the company’s strategy to scale sustainably while promoting healthier food solutions and enhancing long-term investor value.

Despite the operational momentum, MicroSalt’s outlook continues to be weighed down by significant financial weaknesses, including ongoing losses and negative equity. Technical indicators also reflect persistent bearish pressure, with shares trading below major moving averages and flirting with oversold conditions. A negative P/E ratio and lack of dividend yield add to valuation concerns.

More about MicroSalt plc

MicroSalt is an innovator in the global salt market, offering a patented, full-flavour, low-sodium alternative designed for food manufacturers and consumers. Its technology uses micron-sized salt particles to deliver the same taste impact with about 50% less sodium, addressing a major global health challenge. Founded in 2018, the company holds a strong intellectual property portfolio—including a U.S. patent and 14 pending applications worldwide—positioning it for expansion as demand for healthier sodium solutions grows.

Georgina Energy plc (LSE:GEX) has raised £200,000 via the issuance of 4,000,000 new ordinary shares and has also agreed to a debt facility of up to £1,000,000 with an institutional investor. The combined funding package is expected to strengthen the company’s financial flexibility, enabling it to accelerate priority projects and pursue additional growth initiatives. Management views the investment as an important step in reinforcing Georgina Energy’s market position and supporting long-term value creation for shareholders.

Despite these strategic developments, the company continues to grapple with substantial financial pressures, including ongoing losses and strained cash flow. Technical indicators point to neutral momentum, but overall sentiment remains weighed down by the firm’s high-risk financial profile. Investors may want to exercise caution as the company works to stabilize its fundamentals.

More about Georgina Energy plc

Georgina Energy plc is an aspiring energy producer with a focus on helium and hydrogen. Through its wholly owned subsidiary, Westmarket O&G, the company holds two key onshore interests in Australia—one in the Officer Basin of Western Australia and another in the Amadeus Basin in the Northern Territory. Georgina aims to leverage rising global demand for helium and hydrogen by advancing these strategically located projects.

Shield Therapeutics (LSE:STX) has begun a Phase II clinical trial in Japan evaluating ACCRUFeR® (ferric maltol) as a potential treatment for Pulmonary Arterial Hypertension (PAH). The study, led by partner MEDLEAP Pharma, is intended to pave the way for a Phase III programme and prospective regulatory filings targeted for 2028. This marks an important step for ACCRUFeR®, addressing the complex needs of PAH patients who often struggle with long-term iron supplementation, and could position the therapy as a key option within this therapeutic area.

The company’s near-term outlook is shaped by strong technical momentum in its share performance, although substantial financial challenges—including persistent losses and constrained cash flow—continue to weigh on overall sentiment. A negative P/E ratio and absence of dividend yield further limit valuation appeal.

More about Shield Therapeutics

Shield Therapeutics plc is a commercial-stage specialty pharmaceutical company focused on innovative treatments for iron deficiency, with or without anemia. Its flagship product, ACCRUFeR®/FeRACCRU® (ferric maltol), is an oral iron therapy distributed across the U.S., Europe, and Asia through a network of strategic partnerships.

Halfords Group plc (LSE:HFD) has announced plans to publish its interim results for the 26 weeks ending 26 September 2025 on 27 November 2025. The company will release a pre-recorded results presentation online, followed by an in-person strategy update for analysts and institutional investors. Retail investors will also have access to a live Strategy Update through the Engage Investor platform, where they can submit questions directly. The initiative highlights Halfords’ commitment to open communication and deeper stakeholder engagement, steps that could strengthen its market positioning and investor relations.

Halfords’ broader outlook remains mixed. While the group maintains stable operations, profitability constraints remain a notable concern. Positive technical momentum hints at potential near-term upside, but a negative P/E ratio underscores ongoing earnings pressures—partially balanced by an appealing dividend yield. Investors may want to monitor the company’s progress in improving profitability and cash flow discipline.

More about Halfords

Halfords Group plc is the UK’s leading retailer and service provider for motoring and cycling. Its operations span 370 Halfords stores, two Tredz performance cycling outlets, 498 consumer garages, and 92 commercial fleet locations. The company also deploys around 250 mobile service vans and 500 commercial vans, complemented by online retail platforms halfords.com and tredz.co.uk, and its proprietary Avayler software offered on a SaaS basis.

Goldplat plc (LSE:GDP) posted robust operating results for the first quarter ended 30 September 2025, generating a combined operating profit of £2,086,000. Higher gold prices and an improvement in material supply underpinned the company’s performance. Goldplat also announced an interim dividend and intends to evaluate distributions on a quarterly basis going forward.

The Ghanaian business benefited from both a weaker Cedi and firmer gold prices, while South Africa saw profit growth supported by increased feed from South America and disciplined cost control. Across the group, strategic priorities include expanding market share in South Africa, upgrading operational performance in Ghana, and advancing the Tailings Storage Facility project. Strong cash reserves continue to support working capital needs and planned capital investments.

Goldplat’s outlook is underpinned by solid financial fundamentals and appealing valuation metrics, suggesting scope for further growth. While technical signals point to a neutral near-term setup, recent corporate developments—such as anticipated underperformance in certain areas—introduce some short-term risk.

More about Goldplat

Goldplat plc is an AIM-listed mining services company with gold recovery operations in South Africa and Ghana. The group specializes in extracting gold from mining by-products, serving clients across the African and South American mining sectors.

Cindrigo Holdings Limited (LSE:CINH) has been granted a one-year extension for its Worms exploration licence in the Upper Rhine Valley, enabling the company to advance key geothermal development activities. The additional time will support ongoing sub-surface analysis and early-stage environmental assessments—critical steps before moving into the next phase of permitting. The Worms project forms part of Cindrigo’s wider ambition to build up to 300 MW of geothermal capacity in Germany, spanning district heating, power generation, and potential lithium extraction. The extension marks a meaningful milestone for the company’s development roadmap, reinforced by Germany’s supportive policy landscape for geothermal energy.

More about Cindrigo Holdings Limited

Cindrigo Holdings Limited is a renewable energy developer focused on delivering clean, reliable baseload power across Europe. The company operates a 110 MW biomass combined heat and power facility in Finland and is progressing three geothermal projects in Germany. Its strategy centers on creating long-term value through scalable, environmentally sustainable energy solutions.

Picton Property Income (LSE:PCTN) delivered a NAV total return of 3.4% and earnings of 2.9 pence per share for the interim period ending 30 September 2025, marking its twelfth consecutive year of outperforming the MSCI UK Quarterly Property Index. The trust’s ongoing repositioning toward industrial and logistics assets—now the dominant share of its portfolio—has contributed to stronger resilience and growth potential. Combined with a deliberate reduction in short-term debt, Picton believes this strategy sets the stage for rental uplifts and a potential narrowing of the share price discount to NAV.

Picton’s outlook benefits from supportive technical indicators and compelling valuation metrics, although uneven revenue trends and cash flow variability temper the overall picture.

More about Picton Property Income

Picton Property Income is a UK-focused real estate investment trust investing in and managing commercial property. Its portfolio increasingly emphasizes higher-yield industrial and logistics assets, which now account for roughly two-thirds of total holdings.

Melrose Industries PLC (LSE:MRO) reported a strong trading performance for the four months to October 2025, posting a 14% rise in group revenue. The Engines division led the charge with a 28% revenue increase, supported by solid demand in both original equipment and aftermarket services. The Structures division also registered growth, particularly across defense programs, though civil aerospace continued to face supply chain pressures. Despite these challenges, the company reaffirmed its full-year guidance and remains focused on supporting elevated customer demand amid broader industry expansion and shifting geopolitical priorities.

While Melrose’s financial outlook is clouded by pressured cash flows and a recent decline in revenue metrics, upbeat technical indicators point to potential share price strength ahead. The company’s valuation appears balanced, with a mid-range P/E ratio, though a modest dividend yield offers limited appeal for income-driven investors.

More about Melrose

Melrose Industries PLC is a key player in the aerospace and defense sector, supplying advanced engine technologies and structural components for major civil and military aircraft platforms. The company leverages long-standing positions on leading programs and differentiated engineering capabilities to support its growth strategy.